2001
DOI: 10.1159/000047251
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological Characterization of the D1- and D2-Like Dopamine Receptors from the Brain of the Leopard Frog, <i>Rana pipiens</i>

Abstract: The pharmacological profiles of D1- and D2-like dopamine receptors were investigated for native brain receptors in the leopard frog, Rana pipiens, using direct binding assays, which characterize functional receptors rather than assess total receptor protein. We used homogenate assays of R. pipiens fore- and midbrains to determine, via saturation isotherms, that the dissociation constant, Kd, for 3H-SCH-23390 binding to the D1-like receptors was 0.29 nM, and the maximal receptor density, Bmax, was 40… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
6
0

Year Published

2003
2003
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 64 publications
1
6
0
Order By: Relevance
“…The drug doses used in this study are consistent with studies in other amphibians showing effective doses higher than those used in rodents models [Marler et al, 1995;Glagow and Ewert, 1999;Ten Eyck, 2008]. This increase in effective dose may account for physiological differences between amphibians and mammals, such as differences in metabolic rate (ectotherms vs. endotherms) or differences in receptor pharmacology [Chu et al, 2001]. Although a pharmacological characterization of AMPH has not been examined in amphibians, many mechanisms of dopamine pharmacology show a strong conservation of function.…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…The drug doses used in this study are consistent with studies in other amphibians showing effective doses higher than those used in rodents models [Marler et al, 1995;Glagow and Ewert, 1999;Ten Eyck, 2008]. This increase in effective dose may account for physiological differences between amphibians and mammals, such as differences in metabolic rate (ectotherms vs. endotherms) or differences in receptor pharmacology [Chu et al, 2001]. Although a pharmacological characterization of AMPH has not been examined in amphibians, many mechanisms of dopamine pharmacology show a strong conservation of function.…”
Section: Discussionsupporting
confidence: 83%
“…Such conservation of function include the neurotoxic effects of MPTP+ [Barbeau et al, 1985] and 6-hydroxydopamine [Endepols et al, 2004] on dopamine neurons in frog CNS, as well as behavioral effects of the mixed dopamine agonist apomorphine on motor behavior [Glagow and Ewert, 1999;Chu and Wilczynski, 2007;Chu and Rankine, 2008]. Dopamine D1-and D2-like receptors have been pharmacologically characterized in the brain of the northern leopard frog and have been shown to possess binding profiles for various dopaminergic ligands that are similar but not as potent as those of the rat striatum [Chu et al, 2001].…”
Section: Discussionmentioning
confidence: 99%
“…It has been reported that in amphibians, dopamine neurons are localized in the medial brain region, such as the posterior tuberal nucleus and ventral tegmental area, and that they project to the rostral brain region, such as the striatum (32,33). It also has been reported that, as in mammal brain, the amphibian brain possesses dopamine D 1 -and D 2 -like receptors (34) and that both haloperidol and sulpiride abolish dopamine actions in amphibians (35). The present and previous studies with amphibians suggest that the stimulatory effect of 7␣-hydroxypregnenolone on locomotor activity is mediated by the dopaminergic system.…”
Section: Discussionmentioning
confidence: 99%
“…From rostral to caudal, these include a set of periventricular neurons in the preoptic area (POA), a larger population contained within the suprachiasmatic nucleus (SCN), and the most caudal and extensive cell group that occupies the posterior tuberculum (TP) rostrally before moving ventrolaterally into the dorsal hypothalamus (Hy) at the caudal end of the diencephalon. Immunohistochemical studies (Gonzá-lez and Smeets, 1991;González et al 1993;Smeets and Reiner 1995) have shown that these TH-ir cells are dopaminergic, and pharmacological studies by Chu et al (2001) indicate that the forebrain contains both D1-like and D2-like dopamine receptors. Dopaminergic fibers from these cells extend throughout the forebrain and midbrain.…”
Section: Introductionmentioning
confidence: 99%